...
首页> 外文期刊>Therapeutic advances in neurological disorders. >Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies
【24h】

Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies

机译:阴性SARS-COV2-抗体在用抗CD20疗法治疗的患者阳性Covid-19-PCR鼻咽拭子后

获取原文
           

摘要

We report eight patients from our tertiary careneurologic outpatient department treated withanti-CD20 therapies, of which six showed negative SARS-CoV2-antibodies [cut-off value fornegative tests/assay: anti-nucleocapsid IgG 1.4Index Alinity (Abbott, Abbott Park, IL, USA);anti-spike protein IgG 12.0 AU/ml; LiaisonSARS-CoV-2 S1/S2 IgG (DiaSorin, Saluggia,Italy)] after a symptomatic infection with positiveCOVID-19 PCR nasopharyngeal swab. Theremaining two patients had a strong positiveresponse for anti-spike protein IgG (64.6AU/ml)with negative anti-nucleocapsid IgG or a weakpositive response for anti-spike protein IgG(29.3AU/ml) and positive anti-nucleocapsid IgG(2.9 Index), respectively.
机译:我们向八名患者报告了我们的第三级外肠病门诊部治疗的疗法治疗,其中六个显示阴性SARS-COV2-抗体[截止值(禁止价值测试/测定):抗Nuclecapsid IgG 1.4Index别的(Abbott,Abbott Park,IL ,美国);抗穗蛋白IgG 12.0 au / ml; Liaisonsars-CoV-2 S1 / S2 IgG(DiaSorin,Saluggia,意大利)]经过阳性切征-19 PCR鼻咽拭子后。 ThereMird两名患者对抗核蛋白IgG(64.6AU / mL)具有负抗核蛋白衣壳IgG或抗穗蛋白IgG(29.3au / ml)和阳性抗核衣壳IgG(2.9指数 ), 分别。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号